BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250618T090000
DTEND;TZID=Europe/Brussels:20250618T100000
DTSTAMP:20260806T220819
CREATED:20250505T104731Z
LAST-MODIFIED:20250505T104732Z
UID:9039-1750237200-1750240800@www.europabio.org
SUMMARY:BIO Convention 2025 - Panel: The EU Policy Evolution and Revolution for Biotech
DESCRIPTION:Join EuropaBio in Boston for the key EU policy panel taking place at BIO 2025. \n\n\n\nThe EU is reshaping its biotechnology landscape\, with the focus on competitiveness\, supply and capacity resilience and societal benefit. A European Commission 5 year mandate has over 20 legislations and initiatives relevant to biotech and is an opportunity to both anchor and grow European innovation and create an attractive ecosystem for investment for global partners. \n\n\n\nSpeakers from across the European Commission will address the legislations that are the cornerstone of biotechnology performance\, including the EU Biotech Act\, General Pharmaceutical Legislation\, Critical Medicines Act and others. These legislations aim to accelerate the growth of biotech to market and are underpinned by innovative funding models for industry from institutions such as the European Innovation Council. \n\n\n\nJoin the panel to find out how major legislative actions support innovation in the European Union and connect to the European Commission. \n\n\n\nModerator: \n\n\n\n\nClaire Skentelbery\, Director General EuropaBio\n\n\n\n\nSpeakers: \n\n\n\n\nCarmen Laplaza Santos\, Head of Unit Health Innovations and Ecosystems\, DG RTD\, European Commission\n\n\n\nGiulia Del Brenna – Head of Unit – DG GROW\, European Commission\n\n\n\nThomas Van Cangh – Deputy Head of Unit\, DG Sante\, European Commission\n\n\n\nDenisa Perrin– Head of Unit\, EIC Accelerator\, European Innovation Council\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-convention-2025-panel-the-eu-policy-evolution-and-revolution-for-biotech/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/05/Event-Banners-Website-21.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250515T080000
DTEND;TZID=Europe/Brussels:20250516T200000
DTSTAMP:20260806T220819
CREATED:20250527T152347Z
LAST-MODIFIED:20250527T152417Z
UID:9072-1747296000-1747425600@www.europabio.org
SUMMARY:LifeScience4EU Conference 2025
DESCRIPTION:Healthcare innovation is a complex\, interconnected ecosystem that demands collaboration across research\, industry\, policy\, and patient care. To navigate this landscape effectively\, a systems-thinking approach is essential. \n\n\n\nLifeScience4EU Conference 2025\, held under the Polish Presidency of the Council of the European Union\, will bring together top experts to explore how biotechnology\, digital health\, and next-generation medical technologies can drive meaningful change. By aligning innovation with policy and regulation\, the conference aims to build a more resilient and competitive European healthcare sector. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/lifescience4eu-conference-2025/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/05/Event-Banners-Website-23.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250513T160000
DTEND;TZID=Europe/Brussels:20250513T180000
DTSTAMP:20260806T220819
CREATED:20250422T074400Z
LAST-MODIFIED:20250430T072534Z
UID:9000-1747152000-1747159200@www.europabio.org
SUMMARY:Patient BioForum 2025
DESCRIPTION:The theme of the Patient BioForum 2025 is From discovery to access: towards a patient-centric health European ecosystem. \n\n\n\nThe event is hosted by MEP András Tivadar Kulja\, who will hold a keynote speech\, and concluding remarks will be given by MEP Stine Bosse. \n\n\n\nThe panel discussion is moderated by Dr. Nicholas Whyte (Senior Director – APCO) and includes: \n\n\n\nRosa Castro (Public Affairs Director\, EURORDIS)\,  \n\n\n\nLeire Solis\, (Health Policy and Advocacy Director\, IPOPI)\,  \n\n\n\nSolène Jouan (Policy Officer\, European Patients’ Forum)\, \n\n\n\nIrene de Cara Torres (Head of Policy and Government Affairs International\, CSL Behring)\, \n\n\n\nDr. Claire Skentelbery (Director General\, EuropaBio)\, \n\n\n\nRainer Becker (Director SANTE.D Medical Products and Innovation). \n\n\n\n \n\n\n\nThe event gathers patients organisations\, industry leaders and representatives of EU institutions to discuss how the regulatory framework and future legislations (General Pharmaceutical Legislation\, EU Biotech Act and Critical Medicines Act) will support innovation\, availability\, and access to medicines for EU patients. \n\n\n\nEuropaBio’s Patient BioForum aims to facilitate the exchange of views and expertise on scientific\, regulatory\, and policy issues between patient organisations\, the biopharmaceutical industry and policy makers. \n\n\n\nFor more information\, please contact Beatrice Rocco: b.rocco@europabio.org \n\n\n\nRegistrations for people that do not have a badge to access the European Parliament will close at 12:00 on 6 May 2025. People that have a badge can register beyond this date.  \n\n\n\n \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/patient-bioforum-2025/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2025/04/Event-Banners-Website.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250507T000000
DTEND;TZID=Europe/Brussels:20250508T235959
DTSTAMP:20260806T220819
CREATED:20250303T145152Z
LAST-MODIFIED:20250303T145236Z
UID:8834-1746576000-1746748799@www.europabio.org
SUMMARY:Knowledge for Growth 2025
DESCRIPTION:Mark your calendar for Knowledge for Growth 2025\, Europe’s premier life sciences conference\, taking place on 8 May 2025 in the dynamic city of Antwerp\, Belgium! \n\n\n\nConnect with over 1\,000 life sciences professionals from 500+ companies and organisations\, including decision-makers from biotech\, pharma\, MedTech\, AgTech\, and healthtech\, as well as investors\, universities\, research institutes\, policymakers\, and service providers. \n\n\n\nImmerse yourself in an action-packed programme offering exclusive insights into the global and regional life sciences landscape\, one-to-one partnering\, a vibrant trade fair\, and countless networking opportunities. \n\n\n\nDon’t miss the chance to elevate your knowledge and expand your network at Knowledge for Growth 2025! \n\n\n\nUSE CODE: KFG2025CLUSTER15 FOR A 15% DISCOUNT \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/knowledge-for-growth-2025/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/03/Event-Banners-Website-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250505T080000
DTEND;TZID=Europe/Brussels:20250506T200000
DTSTAMP:20260806T220819
CREATED:20250129T083355Z
LAST-MODIFIED:20250217T103904Z
UID:8628-1746432000-1746561600@www.europabio.org
SUMMARY:Swiss Biotech Days
DESCRIPTION:Since 2021\, the Swiss Biotech Day has grown 40% every year and has become a premier global biotechnology conference for life sciences professionals\, fostering international collaboration and impactful partnerships. In 2024 it attracted some 2\,500 participants from more than 40 countries\, including 17 international delegations.Join the Swiss Biotech Day to network\, exchange ideas and explore advances in R&D\, manufacturing\, data management\, AI and innovative financing. In addition\, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments\, public-private partnerships\, R&D collaborations and the exchange of best practices. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/swiss-biotech-days/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2025/01/Event-Banners-Website-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250409T120000
DTEND;TZID=Europe/Brussels:20250409T140000
DTSTAMP:20260806T220819
CREATED:20250327T092235Z
LAST-MODIFIED:20250327T092236Z
UID:8937-1744200000-1744207200@www.europabio.org
SUMMARY:Securing Europe’s biotech future - How can biosecurity drive competitiveness?
DESCRIPTION:Biotechnology involves the use of biological systems\, organisms\, or their components to develop products and solutions across industries such as healthcare\, agriculture\, and manufacturing. In Europe\, it plays an important role in advancing medicine\, sustainability\, and economic growth. Europe accounts for approximately 12% of the global biotech market\, and discussions continue on how to maintain competitiveness in a rapidly evolving sector. Biosecurity ensures biotech technologies are used safely by managing risks and maintaining safety standards. \n\n\n\nOften viewed in the context of risk management and regulation\, it can be overlooked that biosecurity can also play an important role in innovation and market leadership. Biosecurity approaches can affect trust in biotech products\, their attractiveness to investors\, the scalability of new technologies\, and Europe’s position in shaping global standards. As synthetic biology and advanced biomanufacturing tools develop\, discussions on biosecurity frameworks and their impact on investment\, trade\, and competitiveness are ongoing. \n\n\n\nFinding a balance between biosecurity measures and innovation remains a consideration for policymakers and industry stakeholders. At the same time\, Europe’s role in shaping global biosecurity standards is seen as a valuable exercise in its broader economic and security strategy. \n\n\n\nJoin this Euractiv Stakeholder Workshop with our Director General Dr Claire Skentelbery to explore how biosecurity can be a strategic enabler of Europe’s biotech future. Questions to be discussed include: \n\n\n\n\nHow can biosecurity strengthen Europe’s competitiveness in biotech?\n\n\n\nHow can the EU develop a biosecurity approach that supports industrial growth and innovation?\n\n\n\nWhat role can Europe play in shaping global biosecurity standards while maintaining its leadership in biotech?\n\n\n\n\n\nMore Info & Registration Here
URL:https://www.europabio.org/event/securing-europes-biotech-future-how-can-biosecurity-drive-competitiveness/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/03/Event-Banners-Website-8.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250409T080000
DTEND;TZID=Europe/Brussels:20250410T200000
DTSTAMP:20260806T220819
CREATED:20250210T143920Z
LAST-MODIFIED:20250217T103829Z
UID:8693-1744185600-1744315200@www.europabio.org
SUMMARY:German Biotechnology Days
DESCRIPTION:DBT will take place on April 9th ​​and 10th in Heidelberg. The event is considered the German forum for the biotechnology industry\, where entrepreneurs exchange ideas with scientists and partners from politics\, investors\, funding institutions and administration. The two-day program highlights the diverse fields of application and the potential of biotechnology\, from health research to the bioeconomy. \n\n\n\nThe DBT 2025 offers: \n\n\n\n\na good mix of lectures\, panel discussions and breakout sessions\,\n\n\n\nmore than 900 participants\,\n\n\n\nthe largest and most diverse industrial exhibition to date\,\n\n\n\na partnering platform for targeted dating and exchange\,\n\n\n\nevening networking receptions and\n\n\n\nabove all\, plenty of time to get to know each other\, exchange ideas and be inspired.\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/german-biotechnology-days-2/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2025/02/Event-Banners-Website.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250403T133000
DTEND;TZID=Europe/Brussels:20250403T150000
DTSTAMP:20260806T220819
CREATED:20250224T145353Z
LAST-MODIFIED:20250224T145353Z
UID:8810-1743687000-1743692400@www.europabio.org
SUMMARY:Unlocking efficiency through reliance: Navigating the EMA post-authorization framework
DESCRIPTION:This joint webinar\, organised in partnership between the EMA and the industry\, aims to provide a platform for discussion and awareness on current and future EMA post-authorization framework\, including variations and renewals. This event builds up on last year’s session: “Regulatory Reliance Tools Unveiled – A Practical Guide by EMA.” \n\n\n\nThis year\, we will further explore how EMA assessment outputs can support regulatory reliance pathways\, helping to streamline the approval of variations (CMC\, clinical/safety) efficiently and sustainably. \n\n\n\nSpearheaded by EMA\, with the participation of WHO and global regulators\, the webinar will: \n\n\n\n\nExplain EMA’s variations and renewals process.\n\n\n\nDescribe the purpose and content of assessment document outputs and their relevance for regulatory reliance.\n\n\n\nAddress participant questions to enhance understanding and application of these tools.\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/unlocking-efficiency-through-reliance-navigating-the-ema-post-authorization-framework/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/02/Event-Banners-Website-5.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250402T080000
DTEND;TZID=Europe/Brussels:20250403T200000
DTSTAMP:20260806T220819
CREATED:20241204T130548Z
LAST-MODIFIED:20250217T103806Z
UID:8517-1743580800-1743710400@www.europabio.org
SUMMARY:CEBioForum 2025
DESCRIPTION:We warmly invite you to participate in CEBioForum 2025\, one of the key events for business and science in the biotechnology sector in Central Europe! \n\n\n\nOn April 2-3\, 2025\, at the Cambridge Innovation Center in Warsaw\, biotechnology innovation leaders\, scientists\, companies\, and investors will gather to share knowledge\, experiences\, and form new partnerships. \n\n\n\nWhy should you attend CEBioForum? \n\n\n\n\nBusiness networking – Our conference brings together representatives from over 170 biotech companies\, research institutes\, and investors from 21 countries. It’s a perfect opportunity to expand your network\, establish collaborations\, and unlock new business opportunities\, including through our dedicated B2B meeting application.\n\n\n\nExpert insights – Presentations and discussion panels featuring international guests and led by top industry experts. Learn about the latest trends in biotechnology\, innovation financing\, commercialization of inventions\, and expansion into foreign markets.\n\n\n\nLatest innovations – Discover best practices and the newest technological advancements that can accelerate the growth of your company. Explore new funding opportunities and support for research projects.\n\n\n\nShowcase your business – CEBioForum offers a unique chance to present your products and services to a wider audience and investors\, either through presentations or an exhibition booth in our showcase area.\n\n\n\n\nFor over 20 years\, CEBioForum has been connecting scientific and business communities\, creating a space for collaboration and the development of biotechnology projects. Join us and become part of the community shaping the future of biotechnology in Central and Eastern Europe! \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/cebioforum-2025/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/12/External-Events-Banners-600-×-200px-CEBioForum-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250306T080000
DTEND;TZID=Europe/Brussels:20250307T200000
DTSTAMP:20260806T220819
CREATED:20250128T152232Z
LAST-MODIFIED:20250217T103737Z
UID:8625-1741248000-1741377600@www.europabio.org
SUMMARY:4th Hellenic Biocluster Forum: Emerging Trends in Life Science Innovation
DESCRIPTION:Join the 4th Hellenic Biocluster Forum for a 2-day programme discussing all the emerging trends in Life Science Innovation! Get the opportunity to meet stakeholders from the Greek and European innovation ecosystems through B2B partnering opportunities\, meet exhibitors showcasing the latest technology\, pitch to investors and connect to SMEs\, service providers\, big pharma\, and academic institutions. \n\n\n\nKeynote Speakers & RoundTables on: Scaling-up Biotechnology Innovation\, Investment\, Big Data & AI\, Precision Medicine\, Innovative Healthcare\, Bio-Manufacturing\, Technology Transfer into the Market \n\n\n\nWhy do you need to be at the 4th HBio Forum? \n\n\n\n\nA 2-day\, cutting-edge programme on the emerging trends in Life Sciences\n\n\n\nPhysical and digital B2B\n\n\n\nPartnering Opportunities\n\n\n\nExhibition Booths\n\n\n\nOpportunity to meet and present your idea to innovators\, policy makers and investors\n\n\n\nAttend site-visits to Research and Industry partners\n\n\n\n\nWho should attend? \n\n\n\n\nInnovators from SMEs\, startups\, spinoffs\, big pharma\, academia\,\n\n\n\nLife Sciences Clusters and Innovation Agencies\n\n\n\nService Providers\n\n\n\nPolicy Makers\n\n\n\nInvestors\n\n\n\n\nWhat to expect? \n\n\n\n\nGlobal Networking with innovators from across Greece\, Europe and around the globe\n\n\n\nExpert Insights into the latest trends\, technologies and best practices in Life Sciences\n\n\n\nInvestor Connections and Pitch your idea\n\n\n\nOpportunities Exploring Athens!\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/4th-hellenic-biocluster-forum-emerging-trends-in-life-science-innovation/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2025/01/Event-Banners-Website-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250228T090000
DTEND;TZID=Europe/Brussels:20250228T103000
DTSTAMP:20260806T220819
CREATED:20250211T094956Z
LAST-MODIFIED:20250211T094957Z
UID:8724-1740733200-1740738600@www.europabio.org
SUMMARY:B-Trust’s 2nd  masterclass: Co-Creating Trust in Biotech – Cell Factories
DESCRIPTION:How can biotechnology help shape a more sustainable food system? While scientific advancements are creating greener and more innovative ingredients\, gaining consumer trust remains a key challenge.In this exclusive online masterclass\, we’ll explore the role of cell factories – microorganisms that produce specialty food ingredients through fermentation – and their potential to revolutionise food production while reducing land use\, water consumption\, and carbon emissions. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/b-trusts-2nd-masterclass-co-creating-trust-in-biotech-cell-factories/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/02/Event-Banners-Website-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250128T140000
DTEND;TZID=Europe/Brussels:20250128T180000
DTSTAMP:20260806T220819
CREATED:20241126T083629Z
LAST-MODIFIED:20241126T083631Z
UID:8485-1738072800-1738087200@www.europabio.org
SUMMARY:EU Health Summit
DESCRIPTION:Healthy populations are essential for Europe to achieve its vision of a secure\, competitive\, and prosperous continent. Yet\, European health systems are navigating a perfect storm: ageing populations\, rising chronic diseases\, and a health workforce under strain. European societies are facing combined cost-of-living\, geopolitical\, and climate crises with significant implications for healthcare. \n\n\n\nAmid these challenges\, we must not lose sight of the extraordinary era we are living in—one of rapidly advancing science and innovation\, transforming health and unlocking new possibilities for Europe’s present and future generations. \n\n\n\nKeeping the health sector high on the political agenda is essential for the well-being of Europeans\, a resilient workforce\, the growth of the EU economy\, and the security of Europe. This is why\, during this EU mandate\, we need a robust and integrated strategy for health policy. \n\n\n\nWhat needs to be done in practice? \n\n\n\nJoin the EU Health Summit on 28 January to help shape a roadmap for a healthier Europe. \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/eu-health-summit/
CATEGORIES:EuropaBio,External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/External-Events-Banners-600-×-200px-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241225T080000
DTEND;TZID=Europe/Brussels:20241227T200000
DTSTAMP:20260806T220819
CREATED:20241113T103614Z
LAST-MODIFIED:20241113T103616Z
UID:8467-1735113600-1735329600@www.europabio.org
SUMMARY:2nd ESAB Digital Congress
DESCRIPTION:After the successful first digital ESAB Congress last year\, the Scientific Committee has decided that a digital ESAB congress will take place again this year from November 25-27. \n\n\n\nDeadline for abstract submission: 31 October 2024 \n\n\n\nESAB Aims \n\n\n\n\nto take initiatives in areas of growing scientific and industrial interest and importance in the field of applied biocatalysis\n\n\n\n\n\nto identify key topics which may be rate-limiting in the development of scientific progress and technological prospects in applied biocatalysis and to take steps to stimulate these areas\n\n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/2nd-esab-digital-congress/
CATEGORIES:Biomanufacturing Platform,External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/Event-Banner-E-Congress-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241210T080000
DTEND;TZID=Europe/Brussels:20241211T200000
DTSTAMP:20260806T220819
CREATED:20240531T115038Z
LAST-MODIFIED:20240603T072409Z
UID:7883-1733817600-1733947200@www.europabio.org
SUMMARY:The European Bioplastics Conference 2024
DESCRIPTION:We are happy to announce that the EBC 24 will take place on 10/11 December 2024 at the Titanic Hotel Berlin\, Germany.    \n\n\n\nThe European Bioplastics Conference is Europe’s leading business and discussion forum within the global bioplastics sector. More and more brands and manufacturers are embracing the potential of biopolymers\, and policy makers are increasingly streamlining their efforts to create frameworks that benefit the growth of sustainable bio-industries. Now is the time to put bioplastics at the top of the agenda of a biobased circular economy in Europe and beyond. \n\n\n\nThe registration for the EBC 24 is now open and we are excited to welcome you on 10/11 December 2024 in Berlin or online. \n\n\n\nThe hybrid format of this year’s event will again allow you to join either in person at the Titanic Hotel Berlin or comfortably log-in from your home base. Both of which offer unique networking opportunities. \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/the-european-bioplastics-conference-2024/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/05/External-Events-Banners-600-×-200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241122T140000
DTEND;TZID=Europe/Brussels:20241122T160000
DTSTAMP:20260806T220819
CREATED:20241125T083939Z
LAST-MODIFIED:20241125T083942Z
UID:8482-1732284000-1732291200@www.europabio.org
SUMMARY:What's Next for Biotech & Biosecurity: EU & US Post Election Landscape
DESCRIPTION:Join our Healthcare Public Affairs Director\, Vlad Olteanu on Friday 22nd November to listen to What’s next for Biotech and Biosecurity in the EU & US post elections.  \n\n\n\n\nMore information & Registerion Here
URL:https://www.europabio.org/event/whats-next-for-biotech-biosecurity-eu-us-post-election-landscape/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/External-Events-Banners-600-×-200px-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241119T080000
DTEND;TZID=Europe/Brussels:20241119T200000
DTSTAMP:20260806T220819
CREATED:20240619T110353Z
LAST-MODIFIED:20240619T110641Z
UID:7976-1732003200-1732046400@www.europabio.org
SUMMARY:AseBio Green Innovation Forum
DESCRIPTION:Organized by AseBio\, the Spanish Bioindustry Association\, and Sodena the financial agent of the Government of Navarra\, the 5th edition of the AseBio Green Innovation Forum will be held in the Baluarte convention centerof Pamplona on November 19\, 2024. The event will showcase the opportunities that biotechnology can offer as a key tool in the transition towards a more sustainable\, carbon neutral and greener economic model.  The Green Innovation Forum is also firmly committed to achieving the objectives set out in the 2030 Agenda and the European Green Deal. The AseBio Green Innovation Forum will have an agenda of round tables and business meetings in which to address the most relevant aspects of innovation in biotechnology and the green economy. We will also seek to find solutions to medium-long term challenges such as climate change\, industrial transformation\, sustainable food\, or the development of bio-products\, among others. RegistrationRegistration for the Green Innovation Forum 24 is now open. Take advantage of the early bird rates until July 31st. \n\n\n\nPresent your companyCompanies that are members of AseBio or domiciled in Navarra can submit a proposal to present their company before an audience of specialized investors and companies at no extra cost of your registration fee. Sinx-minute presentations will be delivered onsite on November 19th\, 2024. Not all applications will be accepted. A selection committee will review and accept or decline all applications. The deadline to apply: is September 20\, 2024 \n\n\n\nIf you wish to become a member of AseBio please visit our website. \n\n\n\nSponsorship opportunities \n\n\n\nDo you wish to become a sponsor of the Green Innovation Forum? \n\n\n\nGreeen Innovation Forum 2024 will provide you with a unique opportunity to meet face-to-face within Spanish and international  cutting edge companies and research institutions in the green biotech space. \n\n\n\nSponsoring the event will help to create interest in your company\, products and services and also: \n\n\n\n\nRaise your profile within the Spanish and European biotech industry.\n\n\n\n\n\nOther benefits\, as included in the different sponsorship packages.\n\n\n\n\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/asebio-green-innovation-forum/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/06/External-Events-Banners-600-×-200px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241112T090000
DTEND;TZID=Europe/Brussels:20241112T123000
DTSTAMP:20260806T220819
CREATED:20241029T085347Z
LAST-MODIFIED:20241029T085348Z
UID:8437-1731402000-1731414600@www.europabio.org
SUMMARY:Advancing bio-based innovations in the food industry: Focus on fermentation
DESCRIPTION:Join our Director General Dr Claire Skentelbery on the 12th of November in Brussels where she will be speaking at the DG GROW hosted hybrid workshop “Advancing bio-based innovations in the food industry: Focus on fermentation”. \n\n\n\nThe workshop will focus on the industrial applications of fermentation technologies by highlighting SMEs that are using biomass\, precision and gas fermentation. Their innovative technologies will be presented\, along with ways to promote scaling up production. These presentations will be followed by a Q&A session. \n\n\n\nAfter these industry insights\, a panel of experts will discuss topics such as research and innovation\, infrastructure\, the role of farmers\, public acceptance\, market development\, and profitability and pricing. In addition to the fermentation types presented at the beginning of the workshop\, micro fermentation will be discussed. \n\n\n\nDeadline for registrations: 4 November 2024 \n\n\n\n\nMore Information & Register Here
URL:https://www.europabio.org/event/advancing-bio-based-innovations-in-the-food-industry-focus-on-fermentation/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241104T080000
DTEND;TZID=Europe/Brussels:20241106T200000
DTSTAMP:20260806T220819
CREATED:20241009T073025Z
LAST-MODIFIED:20241009T074047Z
UID:8389-1730707200-1730923200@www.europabio.org
SUMMARY:BIO-Europe® 2024
DESCRIPTION:BIO-Europe® 2024 – 30th Annual International Partnering Conference  \n\n\n\nDates:November 4-6\, 2024 | Stockholm\, SwedenNovember 12–13\, 2024 | Digital PartneringVenue: Stockholmsmässan \n\n\n\nVenue address: Mässvägen 1\, 125 80 Stockholm Sweden \n\n\n\nJoin the 30th anniversary edition of BIO-Europe\, the biopharma partnering event that has grown with the industry\, innovated alongside it\, and remains the gathering place for meaningful and memorable conversations and connections. In 2023\, BIO-Europe reached new levels of attendance\, engagement\, and collaboration. 2024 promises to deliver quality opportunities for connection and partnering. The 30th annual BIO-Europe will take place November 4-6\, 2024 in Stockholm\, Sweden\, and it will convene over 5\,500 life science professionals representing more than 2\,800 companies from over 60 countries. Attendees will take part in 29\,000 one-to-one meetings over the course of the event. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-europe-2024/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241023T080000
DTEND;TZID=Europe/Brussels:20241024T200000
DTSTAMP:20260806T220819
CREATED:20241003T082016Z
LAST-MODIFIED:20241003T082123Z
UID:8368-1729670400-1729800000@www.europabio.org
SUMMARY:Regulating the Future of Food Conference
DESCRIPTION:Join our Industrial Biotechnology Senior Manager Lucie McMurtry on the 23rd and 24th of October in Amsterdam where she will be speaking at the Regulating the Future of Food Conference. \n\n\n\nGlobal innovation in food-tech is growing at an incredible pace and there are so many amazing new products and processes out there! This innovation is vital in making a difference to the planet by creating more sustainable and ‘greener’ food systems\, whilst also contributing to economic growth. \n\n\n\nRegulators are doing their best to keep up. They are all working on ways to evolve in line with innovation and create more effective and efficient ways to regulate novel foods\, whilst keeping safety as the key priority. However\, regulations are often seen as a barrier to innovation due to complex frameworks\, a lack of clear guidance and long evaluation timelines. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/regulating-the-future-of-food-conference/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/Healthcare-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241022T080000
DTEND;TZID=Europe/Brussels:20241025T170000
DTSTAMP:20260806T220819
CREATED:20240611T071159Z
LAST-MODIFIED:20240611T071200Z
UID:7930-1729584000-1729875600@www.europabio.org
SUMMARY:World Orphan Drug Congress Europe 2024
DESCRIPTION:The World Orphan Drug Congress Europe is the largest and most established orphan drug & rare disease event worldwide. Meet over 2000 attendees\, hear from 250 leading speakers\, and connect with 130 exhibitors as we bring together experts from the start-to-finish of orphan drugs. From regulation and policy to global pricing and gene therapy\, the Congress has it covered. \n\n\n\nOur attendees include the most senior individuals across the industry\, including; R&D\, Gene Therapy and Rare diseases\, Precision/Personalised Medicine\, Genetic Disorders\, Patient Advocacy and Engagement\, Associations in ATMPs\, Investors\, Regulatory Affairs Professionals\, Governmental Bodies and many more … \n\n\n\nUse code “EUBIO20” to save an additional 20% off the Pharma/Biotech and Standard packages.
URL:https://www.europabio.org/event/world-orphan-drug-congress-europe-2024/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/06/Event-Website-Banner-EBIO-WODC-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241008T100000
DTEND;TZID=Europe/Brussels:20241010T180000
DTSTAMP:20260806T220819
CREATED:20240828T135105Z
LAST-MODIFIED:20240828T135930Z
UID:8158-1728381600-1728583200@www.europabio.org
SUMMARY:CPHI Milan
DESCRIPTION:EuropaBio is pleased to partner with CPHI Milan 2024\, the biggest international pharmaceutical industry event for the thirty fifth anniversary edition. This year’s edition held from the 8th to the 10th of October in Fiera Milano\, Italy promises to a packed agenda with over 150 expert international speakers with over 100 content sessions. \n\n\n\nJoin our Director General Dr Claire Skentelbery this year where she will be speaking on the 9th of October to discuss how cultivated meat has the potential to revolutionise biologic manufacturing. Join her in Hall 3 – 3F97 at 16:15 on 09/10/2024 to find out more. \n\n\n\n \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/cphi-milan/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/08/CPHI-x-EuropaBio-2024-Event-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241002T170000
DTEND;TZID=Europe/Brussels:20241002T193000
DTSTAMP:20260806T220819
CREATED:20240827T080153Z
LAST-MODIFIED:20240827T080535Z
UID:8151-1727888400-1727897400@www.europabio.org
SUMMARY:Enhancing Europe's Pharma and Biotech Competitiveness and Open Strategic Autonomy
DESCRIPTION:Join our Director General Dr Claire Skentelbery on 2 October 2024 where she will be speaking at the Novartis & BritCham event “Enhancing Europe’s Pharma and Biotech Competitiveness and Open Strategic Autonomy”. \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/enhancing-europes-pharma-and-biotech-competitiveness-and-open-strategic-autonomy/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/08/BritCham-Novartis-Event-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240710T080000
DTEND;TZID=Europe/Brussels:20240711T170000
DTSTAMP:20260806T220819
CREATED:20240531T135225Z
LAST-MODIFIED:20240531T135227Z
UID:7893-1720598400-1720717200@www.europabio.org
SUMMARY:CURIOUS­ FUTURE INSIGHT™ CONFERENCE
DESCRIPTION:Over the millennia science & technology have steadily advanced\, but key unsolved challenges remain\, and much more is possible. The Curious – Future Insight™ Conference brings together some of the world’s brightest scientists and most accomplished innovators to present their work and explore the future of science and technology\, solving the challenges of today and enabling the dreams of a better tomorrow. \n\n\n\nThe Curious – Future Insight™ conference featurestop speakers and Nobel laureates from all over theworld\, among them: \n\n\n\n\nEmmanuelle Charpentier\, MPI (2018)\n\n\n\nSteven Chu\, Stanford University (2024)\n\n\n\nRobert Langer\, MIT (2024)\n\n\n\nSatya Nadella\, CEO Microsoft (2018)\n\n\n\nUğur Şahin\, CEO BioNTech (2024)\n\n\n\nRandy Schekman\, Berkeley (2024)\n\n\n\nThomas C. Südhof\, Stanford University (2024\, 2022)\n\n\n\nCraig Venter\, Craig Venter Institute (2018)
URL:https://www.europabio.org/event/curious-future-insight-conference/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Curious-Insights-Banner-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240613T113000
DTEND;TZID=Europe/Brussels:20240613T130000
DTSTAMP:20260806T220819
CREATED:20240513T142126Z
LAST-MODIFIED:20240513T142128Z
UID:7789-1718278200-1718283600@www.europabio.org
SUMMARY:Industrial Biotechnology Day (2nd edition) - Biotechnology as key enabling technology for EU Strategies and Ambitions
DESCRIPTION:Explore how industrial biotechnologies can achieve Europe’s environmental ambitions. Discussions will centre on exploring both regulatory frameworks and technological advancements\, identifying our core strengths and opportunities\, and pinpointing areas for improvement. From evaluating feedstocks and industrial capabilities to overcoming regulatory challenges\, join us in shaping a sustainable path forward for the European chemical industry through biotech innovations. \n\n\n\nThis session is organised by Cefic Sector Groups: EFCG\, EFG and Biochem Europe; EuropaBio and SICOS. \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/industrial-biotechnology-day-2nd-edition-biotechnology-as-key-enabling-technology-for-eu-strategies-and-ambitions/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Healthcare-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240516T090000
DTEND;TZID=Europe/Brussels:20240516T180000
DTSTAMP:20260806T220819
CREATED:20240118T152254Z
LAST-MODIFIED:20240118T152720Z
UID:7279-1715850000-1715882400@www.europabio.org
SUMMARY:Knowledge for Growth
DESCRIPTION:Get ready for the touchdown of Europe’s finest life sciences conference\, Knowledge for Growth\, on May 16\, 2024\, in the vibrant city of Antwerp\, Belgium!Elevate your network by rubbing shoulders with decision-makers from biotech\, pharma\, and MedTech\, alongside investors\, universities\, cutting-edge research institutes\, policymakers\, and competence providers. Join over 1000 life sciences trailblazers representing 500+ companies & organizations! Uncover the future with our riveting programme\, delivering key insights into the global and regional life sciences landscape. Engage in dynamic B2B partnering\, explore groundbreaking innovations at the trade fair\, and seize endless networking opportunities.Ready to be part of the life sciences revolution? Secure your spot now here! #KnowledgeForGrowth #KFG2024  \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/knowledge-for-growth-2/
LOCATION:Flanders Meeting & Convention Center Antwerp
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/01/Event-Banners-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240514T200000
DTEND;TZID=Europe/Brussels:20240515T180000
DTSTAMP:20260806T220819
CREATED:20240311T142703Z
LAST-MODIFIED:20240311T142744Z
UID:7536-1715716800-1715796000@www.europabio.org
SUMMARY:AseBio Investor Day
DESCRIPTION:We are thrilled to announce that AseBio will hold the fifth edition of the AseBio Investor Day at the gorgeous Kursaal conference center in San Sebastián (Spain) on the 15th of May. The AseBio Investor Day is a forum that aims to connect the Spanish biotechnology industry with national and international investors. \n\n\n\nSince its first edition (Barcelona\, 2017)\, the event has attracted national and international investors\, contributing to give visibility to the national biotechnology industry. AseBio Investor Day also fosters networking between investors from Spain and the rest of the world. \n\n\n\nAseBio Investor Day includes a program of round tables where relevant topics on investment and finance will be addressed\, one-to-one meetings and startup pitch presentations. There will also be socials where you can meet your peers and biotech entrepreneurs. \n\n\n\nMeeting Spanish biotechnology is an opportunity to access new deal flow opportunities. Spain is the 9th largest originator of knowledge in biotechnology by number of papers. As of 2023 there were about 900 firms fully dedicated to biotechnology and 270 firms partially dedicated to biotechnology. In 2022 the sector attracted €142 million. \n\n\n\nIn our last edition more than 260 attendees participated in Investor Day and more than 330 one-to-one meetings were held through our matchmaking tool. \n\n\n\nSan Sebastián is a beautiful coastal town in the Spanish Basque Country. The city boasts stunning beaches\, a rich gastronomical tradition with one to the highest densities of Michelin star restaurants in the world\, splendid architecture and a thriving cultural life. The event will take place immediately after BioEquity\, which this year will be held on May 14 and May 15 in the same venue. \n\n\n\nIf you are planning to attend BioEquity why not extend your stay one more day and join us for an opportunity to meet Spanish biotechnology. Investors are cordially invited to participate in the AseBio Investor Day 2024. \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/asebio-investor-day/
LOCATION:Kursaal Zurriola Hiribidea\, 1 20002 Donostia\, Guipuzkoa (Spain)
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/03/Healthcare.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240416T083000
DTEND;TZID=Europe/Brussels:20240416T120000
DTSTAMP:20260806T220819
CREATED:20240326T082922Z
LAST-MODIFIED:20240326T083218Z
UID:7614-1713256200-1713268800@www.europabio.org
SUMMARY:RARE DISEASES FORUM 2024
DESCRIPTION:Against the backdrop of the Belgian EU Council Presidency\, the Rare Diseases Forum 2024 brings together senior leaders from across patient organisations\, industry and policy to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda. \n\n\n\n \n\n\n\nAbout ‘The Rare Diseases Forum 2024: Securing Europe’s Competitiveness in R&D for people living with rare diseases’ features keynotes and panel discussions with a focus on the EU’s role in enhancing competitiveness in life sciences\, fostering investment in the rare diseases sector\, and examining the benefits of a competitive agenda for those with rare diseases.  \n\n\n\nThe event is convened by Global Counsel on behalf of the forum partners\, EURORDIS\, RaDiOrg\, EFPIA\, Eucope\, EuropaBio\, Pharma.be\, UCB\, Novo Nordisk\, Sanofi & Takeda.
URL:https://www.europabio.org/event/rare-diseases-forum-2024/
CATEGORIES:EuropaBio,External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/03/Event-Banner-Website-updated.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240229T090000
DTEND;TZID=Europe/Brussels:20240301T170000
DTSTAMP:20260806T220819
CREATED:20240214T085311Z
LAST-MODIFIED:20240214T100345Z
UID:7415-1709197200-1709312400@www.europabio.org
SUMMARY:International Congress on Rare Diseases and Orphan Drugs 2024
DESCRIPTION:Navigating the Uncharted: Advancements\, Collaborations\, and Hope in Rare Diseases \n\n\n\nSupported by EuropaBio \n\n\n\n \n\n\n\nAbout the event: \n\n\n\nEmbrace the extraordinary journey into the world of rare diseases at our groundbreaking International Congress\, where innovation\, collaboration\, and hope converge! \n\n\n\nThe International Congress on Rare Diseases and Orphan Drugs is organized by Rare Diseases Greece (RDG)\, member of EURORDIS-Rare Diseases Europe and Boussias Events. \n\n\n\nFollowing the success of the previous years and having advanced the policy agenda on both a national and international level\, the Organizing Committee – consisting of Rare Diseases Greece (RDG)\, the 30-member umbrella organization that represents the country’s rare disease community\, brings together all the key initiatives and stakeholders currently shaping the rare disease landscape with the aim to set a course for the future of rare diseases. \n\n\n\nAttendance details: \n\n\n\nThursday\, 29.02.2024 (Hybrid | Technopolis City of Athens Gasholder 1 – Auditorium “Miltiadis Evert”) & Friday\, 01.03.2024 (Digital) \n\n\n\n \n\n\n\n\nRegister here\n\n\n\n\n \n\n\n\n\nFind out more here
URL:https://www.europabio.org/event/international-congress-on-rare-diseases-and-orphan-drugs-2024/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/02/Event-Banner-International-Congress-on-Rare-Diseases-Orphan-Drugs-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240214T080000
DTEND;TZID=Europe/Brussels:20240214T170000
DTSTAMP:20260806T220819
CREATED:20240130T125205Z
LAST-MODIFIED:20240130T125207Z
UID:7333-1707897600-1707930000@www.europabio.org
SUMMARY:Europe Rare Disease Summit 2024
DESCRIPTION:How to improve and learn about Government Plans\, Access & Financing\, Clinical Research and Innovation\, Artificial Intelligence and Data\, and Social & Patient. \n\n\n\nJoin our very own Healthcare Policy Senior Manager\, Adrien Samson in Madrid where he will be speaking in the panel “Innovation\, Funding and Access to Orphan Drugs: Challenges and Opportunities” between 12:15 and 13:00. \n\n\n\n \n\n\n\nWe are thrilled to announce the eagerly awaited second edition of the Europe Rare Disease Summit\, set to take place in February. Joining forces from all corners of Europe\, this prestigious event brings together leading researchers\, healthcare professionals\, patient advocates\, policymakers\, industry experts\, and rare disease patients and families. \n\n\n\nThe summit emphasizes the power of collaboration and solidarity in facing rare diseases. Together\, we can accelerate research\, enhance patient care\, and improve outcomes\, offering a brighter future for those affected by rare diseases. \n\n\n\nKey Objectives: \n\n\n\nEmpowering Patients: Putting patients at the heart of our efforts\, we strive to enhance their access to quality care and support\, while advocating for their rights and unique challenges. \n\n\n\nAdvancing Research: Renowned scientists will present groundbreaking discoveries\, fostering cross-disciplinary collaboration to propel rare disease research forward. \n\n\n\nBuilding Collaborative Networks: A platform for stakeholders to connect\, exchange ideas\, and form strategic partnerships\, bridging gaps in research\, treatment\, and support. \n\n\n\nInfluencing Policy: By engaging policymakers\, we seek to drive positive changes and better support the rare disease community. \n\n\n\nEngaging Program Highlights: Expect a dynamic lineup of keynote speeches\, interactive workshops\, panel discussions and networking opportunities. Share experiences\, learn from experts\, and inspire change. \n\n\n\nLocation and Dates: Prepare to be inspired in the vibrant setting of Madrid on February 14th. \n\n\n\nWho will Attend: \n\n\n\nRare Disease AdvocatesResearchers and ScientistsHealthcare ProfessionalsIndustry LeadersPolicymakers and Government RepresentativesPharmaceutical and Biotech CompaniesInvestors and Venture CapitalistsAcademics and Students
URL:https://www.europabio.org/event/europe-rare-disease-summit-2024/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/01/Event-Banner-ERDS-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240124T120000
DTEND;TZID=Europe/Brussels:20240124T150000
DTSTAMP:20260806T220819
CREATED:20240109T104014Z
LAST-MODIFIED:20240116T095205Z
UID:7234-1706097600-1706108400@www.europabio.org
SUMMARY:EU pharmaceutical legislation - Europe’s biotech innovation in the balance?
DESCRIPTION:Event agenda \n\n\n\n12:00: Registration opens \n\n\n\n12:30: Panel starts \n\n\n\n13:45: Panel close and networking lunch \n\n\n\n15:00: Close \n\n\n\nConfirmed Speakers \n\n\n\nTomislav Sokol MEPMember SANT Committee\, European Parliament \n\n\n\nHilde StevensCo-director\, Institute for Interdisciplinary Innovation in Healthcare (I3H)\, ULB \n\n\n\nKristin ThompsonChief Operating Officer\, eureKARE \n\n\n\nVivian TsevelekiChief Operating Officer\, theraCell \n\n\n\nMore to be announced soon \n\n\n\nIntroduction \n\n\n\nIn April 2023\, the European Commission adopted a proposal for a new Directive and a new Regulation\, aimed at revising and replacing the existing General Pharmaceutical Legislation (GPL). The proposal focuses on modernising the pharmaceutical sector with a patient-centred approach\, while also fully supporting an innovative and competitive industry. \n\n\n\nThrough the proposal\, the EU aims to offer an attractive and innovation-friendly environment for research\, development\, and production of medicines in Europe. The EU plans to create this environment by promoting world-class innovation\, governed by stable and consistent rules that keep pace with innovation and which increase competitiveness while reducing red tape and costs. \n\n\n\nOne of the sectors impacted by the proposal is that of biotechnology\, which has been instrumental in the discovery and development of therapies\, diagnostics\, vaccines and\, most importantly\, advanced medicines. These ‘next generation medicines’ are delivered through a complex and interdependent biotechnology ecosystem\, where companies of all sizes contribute to establishing a pathway to patients. \n\n\n\nJoin this Euractiv Hybrid Conference to discuss Europe’s biotech innovation in light of the EU’s reform of the General Pharmaceutical Legislation.  \n\n\n\nQuestions to be discussed include: \n\n\n\n\nHow can Europe’s biotechnology industry maintain its competitiveness in the global medical market?\n\n\n\nHow can we establish a framework that fosters the growth of small biotech innovators?\n\n\n\nWhat are the reactions of investors to the challenges faced by small biotech companies\, and how do these reactions influence the trajectory of innovation in the biotech industry?\n\n\n\nWhat strategies can be employed to establish a successful innovation pathway for biotech companies\, while considering and aligning with the objectives of the reformed GPL?
URL:https://www.europabio.org/event/eu-pharmaceutical-legislation-europes-biotech-innovation-in-the-balance/
CATEGORIES:All,EuropaBio,External,Healthcare Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/01/EuropaBio.png
END:VEVENT
END:VCALENDAR